1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

Cell lines tested with doxorubicin:navitoclax (2:1 mol/mol)

834 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
IGROV-1 ovary CTRPv22
P3HR-1 haematopoietic and lymphoid tissue CTRPv22
CAL-51 breast CTRPv22
Download CSV

Tissues tested with doxorubicin:navitoclax (2:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2155
lungCTRPv2144
N/ACTRPv247
large intestineCTRPv247
central nervous systemCTRPv245
skinCTRPv243
pancreasCTRPv240
ovaryCTRPv239
breastCTRPv237
stomachCTRPv233
Download CSV
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF445 CTRPv2 AAC 0.27 6e-14
mRNA FAM117B CTRPv2 AAC 0.25 2e-13
mRNA PBRM1 CTRPv2 AAC 0.26 6e-13
mRNA NASP CTRPv2 AAC 0.23 2e-12
mRNA DOT1L CTRPv2 AAC 0.28 3e-12
mRNA MYOF CTRPv2 AAC -0.26 5e-12
mRNA PRR36 CTRPv2 AAC 0.23 1e-11
mRNA KHDRBS1 CTRPv2 AAC 0.23 2e-11
mRNA MEX3A CTRPv2 AAC 0.27 2e-11
mRNA HACE1 CTRPv2 AAC 0.22 2e-11
Download CSV